Cardiovascular disease (CVD) is the primary cause of death in women, and women with type 2 diabetes mellitus are at greater risk of CVD compared with nondiabetic women. The increment in risk attributable to diabetes is greater in women than in men. The extent to which hyperglycemia contributes to heart disease risk has been examined in observational studies and clinical trials, although most included only men or did not analyze sex differences. The probable adverse influence of hyperglycemia is potentially mediated by impaired endothelial function, and/or by other mechanisms. Beyond high blood glucose level, a number of other common risk factors for CVD, including hypertension, dyslipidemia, and cigarette smoking, are seen in women with diabetes and require special attention. Presentation and diagnosis of CVD may differ between women and men, regardless of the presence of diabetes. Recognizing the potential for atypical presentation of CVD in women and the limitations of common diagnostic tools are important in preventing unnecessary delay in initiating proper treatment. Based on what we know today, treatment of CVD should be at least as aggressive in women—and especially in those with diabetes—as it is in men. Future trials should generate specific data on CVD in women, either by design of female-only studies or by subgroup analysis by sex.
Percentage of patients diagnosed with coronary vascular disease, according to risk factors. Percentage of patients diagnosed with coronary vascular disease over 10 years was estimated according to various combinations of risk factors. Each risk factor increases the percentage of patients with diagnosed coronary vascular disease. For all risk factors other than diabetes, the difference between men and women is maintained. In contrast, diabetes closes the gap between men and women (see fifth pair of columns from left). HDL-C indicates high-density lipoprotein cholesterol; plus sign, yes; minus sign, no. To convert cholesterol to millimoles per liter, multiply by 0.0259. Adapted from Kannel5 (1996), with permission.
Relative risk of cardiovascular events in people with diabetes. Except for stroke, the relative risk of cardiovascular disease (CVD) associated with diabetes is greater for women than for men. The dashed line represents a relative risk of 1 (ie, the relative risk expected of a control group). Adapted from Wilson and Kannel6 (1992), with permission.
Relative risks of coronary heart disease (CHD) in women. Relative risks of fatal CHD according to duration of diabetes mellitus (DM) and stratified by a history of CHD. The asterisk indicates that women without a history of CHD who have diabetes for more than 15 years share the relative risk of those with a history of CHD. Adapted from Hu et al18 (2001), with permission.
Hypothetical model of insulin-endothelium interaction. Nitric oxide (NO) released from the endothelial cell diffuses through the subendothelial space to the vascular smooth muscle cell, where it activates guanylate cyclase, which leads to increased cyclic guanosine monophosphate (cGMP) levels. This increase in cGMP initiates a set of reactions that ultimately leads to lower intracellular calcium (iCa) levels, resulting in relaxation of the vascular smooth muscle cell. In vivo, relaxation of the vascular smooth muscle will lead to increased blood flow. L-NMMA indicates NG-monomethyl-L-arginine.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 78
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Users' Guides to the Medical Literature
Example 1: Diabetes and Target Blood Pressure
Users' Guides to the Medical Literature
For example, researchers who conducted a randomized trial of a diabetes education program...
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.